Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
0.9291
+0.0347 (3.88%)
At close: Nov 2, 2026, 4:00 PM EST
0.9300
+0.0009 (0.10%)
After-hours: Nov 2, 2026, 6:22 PM EST
Geron Employees
Geron had 258 employees as of December 31, 2025. The number of employees increased by 29 or 12.66% compared to the previous year. That makes Geron the 24,965th largest employer in the world and 3,200th in the United States.
Employees
258
Change (1Y)
29
Growth (1Y)
12.66%
Revenue / Employee
$792,864
Profits / Employee
-$262,062
Market Cap
596.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 258 | 29 | 12.66% | 258 | 0 |
| Dec 31, 2024 | 229 | 88 | 62.41% | 229 | 0 |
| Dec 31, 2023 | 141 | 34 | 31.78% | 141 | 0 |
| Dec 31, 2022 | 107 | 35 | 48.61% | 107 | 0 |
| Dec 31, 2021 | 72 | 17 | 30.91% | 69 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| DBV Technologies | 170 |
| Neurogene | 131 |
| Bicara Therapeutics | 103 |
| Crescent Biopharma | 69 |
| Zevra Therapeutics | 61 |
| Shattuck Labs | 40 |
| Climb Bio | 29 |
GERN News
- 4 days ago - Geron price target lowered to $5 from $6 at Wedbush - TheFly
- 5 days ago - Geron to discontinue IMpactMF trial - TheFly
- 5 days ago - Geron discontinues late-stage trial of blood cancer drug - Reuters
- 5 days ago - Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis - GlobeNewsWire
- 12 days ago - Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026 - GlobeNewsWire
- 14 days ago - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 21 days ago - Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN - Business Wire